Open Access

[Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling

  • Authors:
    • Feng Gao
    • Fa-Gang Wang
    • Ren-Rong Liu
    • Feng Xue
    • Jian Zhang
    • Guang-Qi Xu
    • Jian-Hai Bi
    • Zhen Meng
    • Ran Huo
  • View Affiliations

  • Published online on: October 20, 2020     https://doi.org/10.3892/ijo.2020.5136
  • Pages: 1383-1383
  • Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

December-2020
Volume 57 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gao F, Wang F, Liu R, Xue F, Zhang J, Xu G, Bi J, Meng Z and Huo R: [Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling. Int J Oncol 57: 1383-1383, 2020
APA
Gao, F., Wang, F., Liu, R., Xue, F., Zhang, J., Xu, G. ... Huo, R. (2020). [Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling. International Journal of Oncology, 57, 1383-1383. https://doi.org/10.3892/ijo.2020.5136
MLA
Gao, F., Wang, F., Liu, R., Xue, F., Zhang, J., Xu, G., Bi, J., Meng, Z., Huo, R."[Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling". International Journal of Oncology 57.6 (2020): 1383-1383.
Chicago
Gao, F., Wang, F., Liu, R., Xue, F., Zhang, J., Xu, G., Bi, J., Meng, Z., Huo, R."[Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling". International Journal of Oncology 57, no. 6 (2020): 1383-1383. https://doi.org/10.3892/ijo.2020.5136